The Czech Experience with Eculizumab in Severe Paediatric Shiga Toxin-Producing Escherichia coli-Associated Haemolytic Uremic Syndrome Patients
- PMID: 33167045
- DOI: 10.1055/a-1288-3597
The Czech Experience with Eculizumab in Severe Paediatric Shiga Toxin-Producing Escherichia coli-Associated Haemolytic Uremic Syndrome Patients
Conflict of interest statement
The authors declare that they have no conflict of interest.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
